跳至主要内容
临床试验/IRCT20200409047007N1
IRCT20200409047007N1已完成未知

The effect of plasma administration of COVID-19 survivors in patients with acute respiratory distress syndrome due to COVID-19

Mashhad University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Po2 / FIO2 ratio less than 300 despite receiving standard treatment
  • The patient should be between 18 and 75 years old
  • Normal IgA level
  • Less than a week has passed since the patient entered the IC

排除标准

  • Uncontrolled HTN
  • Advanced heart failure
  • Systolic blood pressure less than 90 mm Hg
  • The patient is intubated
  • Chronic renal failure with GFR less than 30
  • Advanced hepatic failure

研究者

相似试验